Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
IRON
IRON News & Events
-
Add to Watchlist
Trade IRON
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
IRON News
Pomerantz LLP Investigates Securities Fraud Claims Against Disc Medicine
13 hours ago
Globenewswire
Disc Medicine's Drug Approval Delayed to Feb 10, Stock Rises 2.59%
Jan 16 2026
Benzinga
FDA Delays Disc Medicine's Bitopertin Drug Review, Analysts See Minor Impact
Jan 16 2026
Newsfilter
Disc Medicine's Bitopertin Approval Delayed to February
Jan 15 2026
stocktwits
FDA Delays Review of Fast-Track Drugs Under Trump Administration, Impacting Multiple New Treatments
Jan 15 2026
Benzinga
Disc Medicine (IRON) and Sanofi (SNY) Drug Review Delays Exceed 12 Months
Jan 15 2026
seekingalpha
Disc Medicine Appoints New HR Chief to Support Commercialization Efforts
Jan 12 2026
Globenewswire
Disc Medicine Appoints Lisa Amaya Price as Chief HR Officer to Support Commercialization Efforts
Jan 12 2026
Newsfilter
Show More News
IRON Events
01/15 12:10
Disc Medicine Shares Drop 6.8% to $71.85
Disc Medicine is down -6.8%, or -$5.23 to $71.85.
Show More Events
IRON Monitor News
Disc Medicine's Bitopertin Approval Delayed, Stock Drops
Jan 15 2026
IRON Earnings Analysis
No Data
People Also Watch
